These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24308762)

  • 1. XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.
    Tian XH; Hou WJ; Fang Y; Fan J; Tong H; Bai SL; Chen Q; Xu H; Li Y
    J Exp Clin Cancer Res; 2013 Dec; 32(1):100. PubMed ID: 24308762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XAV939 promotes apoptosis in a neuroblastoma cell line via telomere shortening.
    Tian X; Hou W; Bai S; Fan J; Tong H; Bai Y
    Oncol Rep; 2014 Nov; 32(5):1999-2006. PubMed ID: 25190315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XAV939 inhibits the stemness and migration of neuroblastoma cancer stem cells via repression of tankyrase 1.
    Tian X; Hou W; Bai S; Fan J; Tong H; Xu H
    Int J Oncol; 2014 Jul; 45(1):121-8. PubMed ID: 24789807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells.
    Suebsoonthron J; Jaroonwitchawan T; Yamabhai M; Noisa P
    Anticancer Drugs; 2017 Jun; 28(5):469-479. PubMed ID: 28240680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.
    Wu X; Luo F; Li J; Zhong X; Liu K
    Int J Oncol; 2016 Apr; 48(4):1333-40. PubMed ID: 26820603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.
    Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S
    Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells.
    Bao R; Christova T; Song S; Angers S; Yan X; Attisano L
    PLoS One; 2012; 7(11):e48670. PubMed ID: 23144924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma.
    Chen G; Chen W; Ye M; Tan W; Jia B
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30389710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tanaka N; Mashima T; Mizutani A; Sato A; Aoyama A; Gong B; Yoshida H; Muramatsu Y; Nakata K; Matsuura M; Katayama R; Nagayama S; Fujita N; Sugimoto Y; Seimiya H
    Mol Cancer Ther; 2017 Apr; 16(4):752-762. PubMed ID: 28179481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.
    Koirala S; Klein J; Zheng Y; Glenn NO; Eisemann T; Fon Tacer K; Miller DJ; Kulak O; Lu M; Finkelstein DB; Neale G; Tillman H; Vogel P; Strand DW; Lum L; Brautigam CA; Pascal JM; Clements WK; Potts PR
    Cell Rep; 2020 Jul; 32(3):107922. PubMed ID: 32698014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
    Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
    Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells.
    Zhang J; Si J; Gan L; Guo M; Yan J; Chen Y; Wang F; Xie Y; Wang Y; Zhang H
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):479-487. PubMed ID: 31975621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.
    Vangipuram SD; Buck SA; Lyman WD
    Tumour Biol; 2012 Dec; 33(6):2173-83. PubMed ID: 22886526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
    Stakheev D; Taborska P; Strizova Z; Podrazil M; Bartunkova J; Smrz D
    Sci Rep; 2019 Mar; 9(1):4761. PubMed ID: 30886380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis.
    Guo W; Shen F; Xiao W; Chen J; Pan F
    Oncol Lett; 2017 Dec; 14(6):6585-6591. PubMed ID: 29344117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes.
    Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H
    Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.